Switch to:
More From Other Websites
Rigel Announces Press Release and Conference Call Schedule on Tuesday, August 30, 2016 Sep 17 2016
Rigel's Fostamatinib Meets Primary Endpoint in Phase 3 Study in Chronic ITP Sep 17 2016
Why this Peninsula biotech's layoffs aren't necessarily a bad thing (except for the 46 people losing... Sep 16 2016
Here’s Why These Stocks Are Trending Today Sep 15 2016
RIGEL PHARMACEUTICALS INC Files SEC form 8-K, Costs Associated with Exit or Disposal Activities,... Sep 15 2016
Rigel Restructures to Focus on Fostamatinib Commercialization Sep 15 2016
Rigel Pharmaceuticals cuts 38% of workforce to refocus on fostamatinib Sep 15 2016
Rigel Restructures to Focus on Fostamatinib Commercialization Sep 15 2016
BMO Thinks Rigel's Fostamatinib Market Opportunity Will Be Further Validated Sep 01 2016
ETF’s with exposure to Rigel Pharmaceuticals, Inc. : August 31, 2016 Aug 31 2016
Rigel (RIGL) Stock Up on Positive Phase III Fostamatinib Data Aug 31 2016
Rigel Pharma (RIGL) Stock Jumps on Study Results, Piper Jaffray Ups Price Target Aug 30 2016
What The Latest Data Means For Rigel Pharmaceuticals, Inc. (RIGL) Aug 30 2016
Why Rigel Pharma Is Making a Run Aug 30 2016
Rigel Pharmaceuticals Inc Conference Call to Discuss Its First of Two FIT Phase 3 Results of... Aug 30 2016
Rigel Pharma Claims Late-Stage Study Win for Blood Platelet Drug Aug 30 2016
Rigel's Fostamatinib Meets Primary Endpoint in Phase 3 Study in Chronic ITP Aug 30 2016
RIGEL PHARMACEUTICALS INC Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial... Aug 30 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK